February 26, 2026

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

Conexiant

February 23, 2026

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Conexiant

February 19, 2026

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

Conexiant

February 17, 2026

Statin Side Effects Largely Unsupported by Trial Data

Most adverse effects listed on drug labels lack causal evidence, meta-analysis finds

Conexiant

February 17, 2026

Hospital Prices Posted. Few Patients Look.

Federal rules require hospitals to post prices so patients can shop. Instead, insurers and providers use the data to negotiate what they get paid.

KFF Health News

February 12, 2026

Berberine Evaluated for Liver Fat

Six-month randomized trial finds no reduction in visceral or hepatic fat in patients with obesity and MASLD

Conexiant

February 12, 2026

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

Conexiant

February 11, 2026

Staffing, Flexibility Top Nurses' List to Return

Two-thirds of former hospital nurses would consider coming back if workplace conditions improved, survey finds

Conexiant

February 09, 2026

How Language Shapes Care 

ACP examines ethical implications of calling all physicians “providers”

Conexiant